Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:oral_contraceptive
|
| gptkbp:activeIngredient |
ethinylestradiol
gestodene |
| gptkbp:alternativeName |
Femodene ED
|
| gptkbp:availableOn |
gptkb:Europe
gptkb:United_Kingdom |
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:containsEstrogen |
ethinylestradiol
|
| gptkbp:containsProgestogen |
gestodene
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:marketedAs |
gptkb:Bayer
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskFactor |
increased risk of blood clots
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness mood changes |
| gptkbp:type |
gptkb:oral_contraceptive
|
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:ethinyl_estradiol
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Femodene
|